Concepedia

Stephanie Harlfinger

SH

16

Publications

1.2K

Citations

15

H-Index

2005

Active since

Affiliations

Novartis Institutes for BioMedical Research(Current)

Novartis (Switzerland)

University of Cologne

AstraZeneca (United Kingdom)

AstraZeneca (Sweden)

Stephanie Harlfinger is an author at Novartis Institutes for BioMedical Research specializing in medicine, biochemistry, and pharmacology.

Top concepts

Publications per year

2005–2023

16

Publications

16

Discovery of the ergothioneine transporter

Dirk Gründemann, Stephanie Harlfinger, Stefan Gölz et al. · Proceedings of the National Academy of Sciences · 2005 · 576 citations · Full text

Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol

Stefan Schunk, Klaus Linz, Claudia Hinze et al. · ACS Medicinal Chemistry Letters · 2014 · 90 citations · Full text

Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>

Jason G. Kettle, Sharan K. Bagal, Sue Bickerton et al. · Journal of Medicinal Chemistry · 2020 · 80 citations · Full text

Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations

Silke Grigat, Stephanie Harlfinger, S. Pal et al. · Biochemical Pharmacology · 2007 · 70 citations

, , +7

Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry

Daniela Schreiber, Stephanie Harlfinger, Brit M. Nolden et al. · Analytical Biochemistry · 2006 · 65 citations

, , +8

Rows per page

1–5 of 16